Focal Interest
Focal Interest

Opioid Use Disorder Treatment

External reference: https://openalex.org/T10576

  1. Symptom-based dosing shortened discharge readiness time in NOWS
  2. Alcohol use declined over 72 weeks of wearable membership
  3. Kansas naloxone recipients reported survival after reversals
  4. MOUD use rose across most states among Medicaid beneficiaries with OUD
  5. Buprenorphine linked to no higher neurodevelopmental risk than methadone
    Population-based cohort study comparing neurodevelopmental outcomes in children prenatally exposed to buprenorphine versus methadone for maternal opioid use disorder treatment.